• ÆäÀ̽ººÏ °øÀ¯
  • Æ®À§ÅÍ °øÀ¯
  • ¹ÌÅõµ¥ÀÌ °øÀ¯
  • URLº¹»ç
  • ´õº¸±â
  • °ü½ÉÀÇ·áÁø µî·Ï

Á¶°æÈñ

Á¶°æÈñ

Á¶°æÈñ ±³¼öÀÇ Áø·á½Ã°£Ç¥ Áø·á¿¹¾à

Áø·á°ú/¼¾ÅÍ ¿ù È­ ¼ö ¸ñ ±Ý Åä Àü¹®Áø·á°ú¸ñ
½Å°æ°ú
¿ÀÀü
-
Á¾ÀÏ
¿ÀÈÄ
- - ³úÁ¹Áß , ³úÇ÷°ü Áúȯ , µÎÅë
³ú½Å°æ¼¾ÅÍ
¿ÀÀü
-
Á¾ÀÏ
¿ÀÈÄ
- - ³úÁ¹Áß , ³úÇ÷°ü Áúȯ , µÎÅë

Á¶°æÈñ ±³¼öÀÇ »ó¼¼Á¤º¸

ÇзÂ

more
  •  ~  2008 .02  :  ¿ï»ê´ëÇб³ ÀÇÇдëÇпø ½Å°æ°úÇÐ ¹Ú»ç
  • 2004 .03  ~  2006 .02  :  ¿ï»ê´ë ÀÇÇÐ ¼®»ç
  • 1995 .03  ~  2001 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ Çлç

°æ·Â

more
  • 2015 .03  ~   :  °í·Á´ëÇб³ Àǰú´ëÇÐ ÀÇÇаú ½Å°æ°ú ºÎ±³¼ö
  • 2012 .09  ~  2015 .02  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ÀÇÇаú ½Å°æ°ú Á¶±³¼ö
  • 2011 .09  ~  2012 .08  :  °í·Á´ëÇб³ Àǰú´ëÇÐ ÀÇÇаú ½Å°æ°ú ÀÓ»óÁ¶±³¼ö
  • 2009 .09  ~  2011 .08  :  °è¸í´ëÇб³ Àǰú´ëÇÐ ÀÇÇаú ½Å°æ°ú ÀüÀÓ°­»ç
  • 2008 .03  ~  2009 .08  :  °è¸í´ëÇб³ µ¿»êÀÇ·á¿ø ¿¬±¸°­»ç
  • 2006 .03  ~  2008 .02  :  ¼­¿ï¾Æ»êº´¿ø ½Å°æ°ú ÀÓ»ó°­»ç
  • 2002 .03  ~  2006 .02  :  ¼­¿ï¾Æ»êº´¿ø ½Å°æ°ú ·¹Áö´øÆ®
  • 2001 .03  ~  2002 .02  :  ¼­¿ï¾Æ»êº´¿ø ÀÎÅÏ

¼ö»ó³»¿ª

more
  • 2006  :  ¿ï»ê´ëÇб³ ÀÇÇдëÇпø Á¾ÇÕÇмú´ëȸ ¿ì¼ö³í¹®»ó
  • 2007  :  ´ëÇѳúÁ¹ÁßÇÐȸ ¿¬±¸°úÁ¦°ø¸ð´ç¼± ¿¬±¸ºñ¼öÇý
  • 2008  :  ´ëÇѽŰæ°úÇÐȸ ±¸¿¬ ¿ì¼ö ¹ßÇ¥»ó
  • 2010  :  °è¸í´ëÇб³ ºñ»ç¿¬±¸ºñ ¼öÇý
  • 2010  :  °è¸í´ëÇб³ ³ú¿¬±¸¼Ò ¿¬±¸ºñ ¼öÇý
  • 2012  :  °í·Á´ëÇб³ ½ÅÀÓ±³¿øÁ¤Âø¿¬±¸ºñ ¼öÇý

ÇÐȸȰµ¿

more
  •  ~   :  ´ëÇѽŰæ°úÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇѳúÁ¹ÁßÇÐȸ Á¤È¸¿ø
  •  ~   :  ´ëÇÑÀÓ»ó½Å°æ»ý¸®ÇÐȸ ±³À°À§¿øÈ¸

³í¹®

more
  • [±¹¿Ü³í¹®] (Takotsubo-like myocardial dysfunction in ischemic stroke: A hospital-based registry and systematic literature review)
  • [±¹¿Ü³í¹®] (Prestroke antiplatelet agents in first-time ischemic stroke are related to subtypes)
  • [±¹¿Ü³í¹®] (Chronic kidney disease and intravenous thrombolysis in acute stroke: A systematic review and meta-analysis)
  • [±¹¿Ü³í¹®] (Ischemic stroke related to an amniotic fluid embolism during labor)
  • [±¹¿Ü³í¹®] (Prestroke antiplatelet agents in first-ever ischemic stroke: Clinical effects)
  • [±¹¿Ü³í¹®] (Circadian variation of stroke onset and other clinical characteristics: a single-center study)
  • [±¹¿Ü³í¹®] (Susceptibility vessel signs on T2*-Weighted Gradient Echo Images in patients with cerebral atherosclerosis)
  • [±¹¿Ü³í¹®] (Effective mechanical thrombectomy in a patient with hyperacute ischemic stroke associated with cardiac myxoma)
  • [±¹¿Ü³í¹®] (Statins improve survival in patients with cardioembolic stroke)
  • [±¹¿Ü³í¹®] (Factors associated with post-stroke anger proneness in ischemic stroke patients)
  • [±¹¿Ü³í¹®] (Leptomeningeal collaterals are associated with modifiable metabolic risk factors)
  • [±¹¿Ü³í¹®] (Early Infarct Growth Predicts Long-Term Clinical Outcome after Thrombolysis.)
  • [±¹¿Ü³í¹®] (Post-stroke depression and emotional incontinence: factors related to acute and subacute stages.)
  • [±¹¿Ü³í¹®] (Cerebral infarct in a patient with a previous history of systemic arterial and venous thrombosis from essential thrombocythemia.)
  • [±¹¿Ü³í¹®] (Factors and Outcomes Associated with Recanalization Timing after Thrombolysis.)
  • [±¹¿Ü³í¹®] (Forced suction thrombectomy of an arterial tumor embolism due to metastatic melanoma. )
  • [±¹¿Ü³í¹®] (. Symptomatic hemorrhagic transformation and its predictors in acute ischemic stroke with atrial fibrillation.)
  • [±¹¿Ü³í¹®] (Lesion volume increase is related to neurologic progression in patients with subcortical infarction.)
  • [±¹¿Ü³í¹®] (Isolated labyrinthine infarction as a harbinger of anterior inferior cerebellar artery territory infarction with normal diffusion-weighted brain MRI.)
  • [±¹¿Ü³í¹®] (Basilar artery atherosclerotic disease is related to subacute lesion volume increase in pontine base infarction.)
  • [±¹¿Ü³í¹®] (Location of single subcortical infarction due to middle cerebral artery atherosclerosis: proximal versus distal arterial stenosis.)
  • [±¹¿Ü³í¹®] (Differential patterns of evolution in acute middle cerebral artery infarction with perfusion-diffusion mismatch: atherosclerotic vs. cardioembolic occlusion.)
  • [±¹¿Ü³í¹®] (Significance of susceptibility vessel sign on T2*-weighted gradient echo imaging for identification of stroke subtypes.)
  • [±¹¿Ü³í¹®] (Embolic Infarction Associated with Cardiac Amyloidosis.)
  • [±¹³»³í¹®] ±Þ¼º³ú°æ»ö°ú ¸»ÃÊ»öÀüÁõÀÌ ÇÔ²² ¹ß»ýÇÑ ½ÉÀåÁ¡¾×Á¾ ȯÀÚ
  • [±¹³»³í¹®] °í°­µµ ¿ÍÆÄ¸° Åõ¾à ÈÄ ³­Ä¡µÎÅëÀÌ È£ÀüµÈ Ç×ÀÎÁöÁúÇ×üÁõÈıº 1¿¹
  • [±¹³»³í¹®] Àڹߵΰ³³»¾ÐÀúÇÏ È¯ÀÚ¿¡¼­ °æ¸·¿ÜÇ÷¾×øÆ÷¼ú ÈÄ ¹ß»ýÇÑ µÎ°³³»¾Ð»ó½Â
  • [±¹³»³í¹®] Áö¼ÓÀûÀÎ ±¸ÅäÁõ»óÀ» º¸ÀÎ ¼Ò³ú°æ»ö ȯÀÚ¿¡¼­ ¹ß»ýÇÑ ¸»·Î¸®-¹ÙÀ̽º ÁõÈıº
  • [±¹³»³í¹®] ¹ßÀÛ¼º ½É¹æ¼¼µ¿ ȯÀÚ¿¡¼­ Àü±ØµµÀÚÀýÁ¦¼ú ÀÌÈÄ ¹ß»ýÇÑ ³ú°æ»ö
  • [±¹³»³í¹®] 2013³â Çѱ¹³úÁ¹ÁßÁø·áÁöħ °³Á¤°ú ±Ù°Å¿¡ ´ëÇÑ °íÂû
  • [±¹³»³í¹®] Çѱ¹ ³úÁ¹Áß Áø·áÁöħ ±Þ¼º±â Ä¡·á Áß Ç÷Àü¿ëÇØ¼ú¿¡ ´ëÇÑ ³»¿ëÀÇ ºÎºÐ°³Á¤
  • [±¹³»³í¹®] °ú´ÙÈ£»ê±¸ÁõÈıº°ú ¿¬°üµÈ ³ú°æ»ö º´º¯ÀÇ ¾ç»ó
  • [±¹³»³í¹®] ¾Æ½ºÇǸ°À» º¹¿ëÇÏ´ø ±Þ¼º ³ú°æ»ö ȯÀÚ¿¡¼­ »ýÈ­ÇÐÀû ¾Æ½ºÇǸ°ÀúÇ×¼ºÀÌ ³ú°æ»öÀÇ ÁßÁõµµ¿¡ ¹ÌÄ¡´Â ¿µÇâ
  • [±¹³»³í¹®] °¡¿ª¼º ³úÇ÷°ü¼öÃàÁõÈıº°ú ¿¬°üµÈ ¾çÃø¼º Àü´ë³úµ¿¸Æ°æ»öÁõ
  • [±¹³»³í¹®] ±Þ¼º±â ³úÁ¹Áß Áø·áÁöħ-Ç÷Àü¿ëÇØ¼ú
  • [±¹³»³í¹®] °æµ¿¸Æ ½ºÅÙÆ® ¼³Ä¡ ÀÌÈÄ¿¡ »ý±ä ¸Á¸·µ¿¸ÆÀÇ Æó»ö: Áõ·Ê º¸°í
  • [±¹³»³í¹®] ÀÚ±â°ø¸í¿µ»ó±â±â¿¡¼­ ½ÉÇÑ ÀÚ±âÈ­À²ÀΰøÀ½¿µÀÌ ÀÖÀ» ¶§ PROPELLERÈ®»ê°­Á¶¿µ»óÀÇ À¯¿ë¼º: Áõ·Êº¸°í
  • [±¹³»³í¹®] Ÿī¾ß¼ö µ¿¸Æ¿°À» °¡Áø ȯÀÚ¿¡¼­ Áß³úµ¿¸Æ Æó¼â¿Í ³ú°æ»ö
  • [±¹³»³í¹®] ÇãÇ÷¼º ³úÁ¹Áß È¯ÀÚ¿¡¼­ MTHFR C677T ´ÜÀÏ ¿°±â ´ÙÇü¼ºÀÌ ºñŸ¹Î¿¡ ÀÇÇÑ Ç÷Àå È£¸ð½Ã½ºÅ×ÀÎ ³óµµ °¨¼Ò¿¡ ¹ÌÄ¡´Â ¿µÇâ.
  • [±¹³»³í¹®] Metronidazole Áßµ¶Áõ: ÀÓ»ó-½Å°æ¿µ»ó ¼Ò°ßÀÇ ºÒÀÏÄ¡¸¦ º¸ÀÎ 2¿¹
  • [±¹³»³í¹®] ³ú¼¶¿±ÀÇ °æ»öÀ¸·Î ¹ß»ýÇÑ ¼ø¼ö ¸»½ÇÇàÁõ
  • [±¹³»³í¹®] ±Þ¼º ÁõÈļº ³»°æµ¿¸Æ Æó»ö ȯÀÚ¿¡¼­ ÀÀ±ÞÀ¸·Î ½ÃÇàÇÑ µÎ°³¿Ü-µÎ°³³» µ¿¸ÆÃø·Î¼ú 1¿¹
  • [±¹³»³í¹®] ¼±ÅÃÀû »ïÂ÷½Å°æ ¿µ¿ªÀÇ °¨°¢ÀúÇÏ·Î ¹ßÇöµÈ »ïÂ÷½Å°æ±ÙÀ¸·Î È®ÀåµÈ ³ú±³ÃâÇ÷ 1¿¹
  • [±¹³»³í¹®] Á¦ 3ÆÇ Wechsler ±â¾ï°Ë»ç¸¦ ÀÌ¿ëÇÑ ³»ÃøµÎ¿± °£Áú ȯÀÚÀÇ º´º¯ ÃøÀ§¿¡ ´ëÇÑ Æò°¡
  • [±¹³»³í¹®] µÎ ¹øÀÇ ¿¬¼ÓÀû ³ú°æ»ö¿¡ ÀÇÇÑ ¾çÃø¼º ¿ÜÃø¿¬¼öÁõÈıº 1¿¹

ÃÖÁ¾¼öÁ¤ÀÏ : 2020.09.14